More Ways to Connect
  LinkedIn Twitter YouTube Instagram
  RSS
Search
News

University of Cincinnati Academic Health Center
Publish Date: 11/17/98
Media Contact: AHC Public Relations, (513) 558-4553
print
PDF download
RSS feed
related news
share this
Epilepsy Treatment Program Offers Comprehensive Services

Cincinnati--November is National Epilepsy Awareness Month. Epilepsy is a disorder of brain function that can recur throughout a person’s life. About 1 to 2 percent of the world population develops the disorder, and the exact cause can be identified in only about half of the cases.

Treatment focuses on seizure-control so the person can lead a normal life. Standard medications can eliminate seizures in most people. The Comprehensive Epilepsy Treatment Program specializes in the advanced treatment strategies required for the 25 percent who have uncontrolled seizures.

“Epilepsy monitoring enables doctors to pinpoint the exact site in the brain that causes electrical brain storms to occur in about 80 percent of all cases,” says Michael Privitera, MD, professor of neurology, University of Cincinnati (UC) College of Medicine, and director of the Comprehensive Epilepsy Treatment Program of the Neuroscience Institute. “If the targeted tissue can be vaporized with a laser without affecting normal brain tissue, the person with epilepsy can drastically reduce or eliminate the need for medications that control seizures,” says Privitera.

UC Medical Center experts operate Cincinnati’s only epilepsy monitoring program, located at The University Hospital. Privitera says, “We have more than ten years of experience and have evaluated thousands of patients.” The Comprehensive Epilepsy Treatment Program is comprised of four physicians, three nurses, a neuropsychologist, nine EEG technicians, and support staff. UC’s comprehensive approach to epilepsy includes medical and surgical treatments, patient education, and support services for patients and loved ones.

UC Medical Center is one of the world’s leading centers for testing new epilepsy treatment drugs and was instrumental in the development of four of the five new FDA-approved drugs to control seizures. For more information about the Comprehensive Epilepsy Monitoring and Treatment Program of the Neuroscience Institute, call (513) 475-8730 or 584-4405.


 back to list | back to top